Holen Sie sich die Stockscreener-App
0.95
1.07%
-0.0103
Handel nachbörslich:
.89
-0.06
-6.32%
Oncolytics Biotech Inc Aktie (ONCY) Neueste Nachrichten
Oncolytics Biotech Establishes $75 Million ATM Offering - TipRanks
Oncolytics Biotech (NASDAQ: ONCY) sets up $75M ATM facility - stocktitan.net
Oncolytics Biotech (NASDAQ: ONCY) launches $75M ATM with Jefferies - stocktitan.net
Oncolytics (ONCY) Targets FDA Meeting for Pelareorep's Anal Canc - GuruFocus
Oncolytics (ONCY) Targets FDA Meeting for Pelareorep's Anal Cancer Pathway - gurufocus.com
Oncolytics schedules FDA meeting on anal cancer drug pathway By Investing.com - Investing.com India
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study - tipranks.com
Oncolytics Biotech schedules Type C FDA meeting to discuss single-arm registrational study for pelareorep in anal cancer - TradingView
Oncolytics Biotech (NASDAQ: ONCY) targets single-arm pivotal SCAC path - stocktitan.net
Oncolytics Biotech Inc announces a meeting focused on its single-arm pivotal study of candidate drug Pelareorep in second-line and later metastatic colorectal adenocarcinoma (SCAC) patients - Bitget
Rare anal cancer with few options drives Oncolytics' FDA trial push - stocktitan.net
Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Consensus Rating of "Moderate Buy" from Analysts - marketbeat.com
[EFFECT] ONCOLYTICS BIOTECH INC SEC Filing - stocktitan.net
Oncolytics Biotech (NASDAQ:ONCY) Upgraded to Hold at Wall Street Zen - MarketBeat
Oncolytics Biotech Inc. (ONCY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Oncolytics Biotech: Revenue and Earnings Analysts Forecasts Revisions | ONYN | US68237V1035 - marketscreener.com
Oncolytics Biotech Inc.: Performance & Quotes, ONCY Stock Price on Nasdaq Exchange - marketscreener.com
Oncolytics Biotech: Financial Data Forecasts Estimates and Expectations | ONYN | US68237V1035 - marketscreener.com
Oncolytics Biotech: Target Price Consensus and Analysts Recommendations | ONYN | US68237V1035 - marketscreener.com
Oncolytics Biotech’s U.S. Move Resets Regulatory Path And Valuation Debate - Sahm
Oncolytics Biotech: Target Price Consensus and Analysts Recommendations | ONCY | US68237V1035 - marketscreener.com
Oncolytics Biotech Inc.: Financial Data Forecasts Estimates and Expectations | ONCY | US68237V1035 - marketscreener.com
Oncolytics Biotech: Revenue and Earnings Analysts Forecasts Revisions | ONCY | US68237V1035 - MarketScreener
Oncolytics Biotech Inc.: Fundamental Analysis and Financial Ratings | ONCY | US68237V1035 - marketscreener.com
ONCY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Oncolytics Biotech Inc. (ONCY) stock price, news, quote and history - Yahoo Finance Singapore
Oncolytics Biotech Completes Domicile Change to the United States - MarketScreener
Stocks in play: Oncolytics Biotech Inc - Barchart
Oncolytics Biotech Inc. (ONCY) latest stock news and headlines - sg.finance.yahoo.com
ONCY Stock Price, Quote & Chart | ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) - ChartMill
Oncolytics Biotech® Completes Domicile Change to the United States - Sahm
Oncolytics completes reincorporation from Canada to Nevada By Investing.com - Investing.com South Africa
Oncolytics Biotech | 10-K: FY2025 Annual Report - Moomoo
Oncolytics Biotech’s Nevada Move Resets Capital Access And Dilution Trade Off - Yahoo Finance
Oncolytics Biotech Completes Domestication to Nevada with New Governance - TipRanks
Oncolytics (ONCY) Completes Move to US Incorporation - GuruFocus
Oncolytics Biotech (NASDAQ:ONCY) Releases Earnings Results, Misses Expectations By $0.02 EPS - marketbeat.com
Oncolytics completes reincorporation from Canada to Nevada - Investing.com
Oncolytics Biotech Completes Move to U.S., Becomes Nevada Corporation and Sets San Diego as New Headquarters - Minichart
[8-K] ONCOLYTICS BIOTECH INC Reports Material Event - stocktitan.net
Oncolytics Biotech (ONCY) re-registers $139M; $250M shelf available - stocktitan.net
ONCY SEC FilingsOncolytics Biotech Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Outlook: Is Oncolytics Biotech Inc undervalued by DCF analysis2026 Price Swings & Real-Time Volume Analysis - baoquankhu1.vn
[POS AM] ONCOLYTICS BIOTECH INC SEC Filing - stocktitan.net
Aug Setups: Can Oncolytics Biotech Inc expand its profit margins2026 Geopolitical Influence & AI Forecasted Stock Moves - baoquankhu1.vn
Oncolytics Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Oncolytics Biotech (NASDAQ: ONCY) flags going concern and funding risk - stocktitan.net
Sentiment Recap: Will Oncolytics Biotech Inc outperform the market in YEAR2026 Snapshot & Verified Momentum Stock Watchlist - baoquankhu1.vn
Is It Time To Reassess Oncolytics Biotech (ONCY) After Recent Trial Progress News? - Sahm
Aug Closing: Is Oncolytics Biotech Inc stock a good dividend stock2026 Setups & Free Long-Term Investment Growth Plans - baoquankhu1.vn
If You Invested $1,000 in Oncolytics Biotech Inc (ONCY) - stocktitan.net
Oncolytics Biotech Inc. Adopts New Articles and Notice of Articles Following Continuance to British Columbia Corporate Law - Minichart
Oncolytics Biotech completes first step of redomestication to British Columbia - Investing.com UK
Oncolytics Biotech completes first step of redomestication to British Columbia By Investing.com - Investing.com India
Form 8K Oncolytics Biotech Inc. For: 20 March By Investing.com - Investing.com South Africa
Form 8K Oncolytics Biotech Inc. For: 20 March - Investing.com
Oncolytics Biotech Shifts Corporate Domicile to British Columbia - TipRanks
Oncolytics Biotech (NASDAQ: ONCY) outlines move from Canada to Nevada - stocktitan.net
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):